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Abstract 
Background: Current efforts to develop stem cell therapy as a novel treatment for neurointestinal 
diseases are limited by the unavailability of a model system to study cell transplantation in the 
human intestine. We propose that xenograft models support enteric nervous system (ENS) 
development in the fetal human intestine when transplanted into mice subcutaneously or intra-
abdominally. 
Methods: Fetal human small and large intestine were grafted onto the small intestinal mesentery 
and into the subcutaneous tissue of immunodeficient mice for up to 4 months. Intestinal 
cytoarchitecture and ENS development were studied using immunohistochemistry. 
Key Results: In both abdominal and subcutaneous grafts, the intestine developed normally with 
formation of mature epithelial and mesenchymal layers. The ENS was patterned in two 
ganglionated plexuses containing enteric neurons and glia, including cholinergic and nitrergic 
neuronal subtypes. c-Kit-immunoreactive interstitial cells of Cajal were present in the gut wall.   
Conclusions: Abdominal xenografts represent a novel model that supports the growth and 
development of fetal human intestine. This in vivo approach will be a useful method to study 
maturation of the ENS, the pathophysiology of neurointestinal diseases, and the long-term 
survival and functional differentiation of neuronal stem cells for the treatment of enteric 
neuropathies. 
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Key Messages 
1. Reliable and experimentally tractable models are needed to study the pathophysiology of 
enteric neuropathies and to develop novel cell-based treatments for these diseases.  
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2. The enteric nervous system of fetal human intestine develops normally in murine 
subcutaneous and abdominal xenografts. 
3. Abdominal xenografts represent a novel and useful method for studying the enteric 
nervous system, neurointestinal diseases, and enteric neuronal stem cell transplantation. 
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Introduction  
Much of our understanding of developmental and pathophysiological processes in the human 
gut has been based on results of studies of experimental animal models. However, translational 
research requires models that use human intestine. Most studies of the human gastro-intestinal 
system at the cellular and molecular level have relied either on biopsy material, organ cultures, 
or human cell lines. However, the ability to study development, physiology and pathophysiology 
of the human enteric nervous system (ENS) using these models is limited. In particular, the 
potential development of enteric neuronal stem cell (ENSC) therapy as a promising approach to 
replace missing or abnormal neurons in patients with enteric neuropathies would be facilitated by 
an experimental platform in which 1) the tissue is of human origin and 2) the disease can be 
induced and therapy implemented and evaluated over time.   
One approach to the study of the human gut has been to transplant human fetal gut 
subcutaneously in immunosuppressed mice (1, 2).  This model has been described in detail, and 
has primarily been used for study of enteropathogen-host interactions (3-10). However, with the 
exception of one acknowledgement that the myenteric plexus exists in these human xenografts 
(1), there has been no mention of the ENS in any studies of this model. Here, we describe the 
characteristics of the ENS in human fetal gut transplanted and maintained in SCID mice over the 
course of several months. We show that the fundamental neuronal and glial cell types and 
neuronal organization in the xenografts are as expected from samples of normal human tissue. 
We also describe a novel experimental model which entails transplanting human fetal gut onto 
the mesentery in the mouse abdominal cavity, adjacent to the host gut. Here too, the donor gut 
demonstrates normal cytoarchitecture and cellular differentiation, including formation of a 
normal enteric nervous system. These novel experimental platforms provide a robust system for 
long-term studies of human intestine and for furthering the development of cell-based therapies 
for neurointestinal diseases.  
 
Materials and Methods 
SCID mouse human intestinal xeno-transplant models 
C.B-17/IcrHsd-Prkdcscid (SCID) mice were purchased from Harlan Biotech Israel 
(Rehovot, Israel). All mice were housed in a pathogen-free facility in individually ventilated cages 
(IVC), given autoclaved food and water. All animal use was in accordance with the guidelines and 
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approval of the Animal Care and Use Committee (IACUC) of the Hebrew University of Jerusalem. 
IRB and IACUC approvals were obtained (Ethics Committee for Animal Experimentation, 
Hebrew University of Jerusalem (MD-11-12692-4) and the Helsinki Committee of the Hadassah 
University Hospital (81-23/04/04).  
Women undergoing legal termination of pregnancy gave written, informed consent for use 
of fetal tissue in this study. Human fetal small bowel 12-18 weeks gestational age was implanted 
subcutaneously on the dorsum of the mouse as described previously (3-5) or intra-abdominally as 
described below. All surgical procedures were performed in an aseptic environment in a laminar 
flow HEPA-filtered hood with isoflurane inhalation anesthesia (1.5 to 2% v/v isofluorane in O2). 
Before surgery, carprofen (5 mg/kg, Rimadyl, Pfizer Animal health) was administered 
subcutaneously. The surgical area was shaved and depilated and the skin was scrubbed and 
disinfected with betadine and 70% (v/v) ethanol. For abdominal transplant, a midline vertical 
incision was made through the skin and abdominal wall exposing the peritoneal cavity and a small 
segment of mouse jejunum was exteriorized. Next, a 20-25 mm long segment of human fetal gut 
was placed on the intestinal mesentery adjacent to the jejunum. 3M Vetbond Tissue Adhesive (n-
butyl cyanoacrylate) was used to seal both ends of the fetal gut segment and to fix it to the jejunum. 
Care was taken to avoid injuring the mouse mesenteric vessels. The abdomen was closed using 
standard surgical techniques. After surgery the mice were provided with enrofloxacin-medicated 
water (Bayer Animal HealthCare AG) for 7 days and closely monitored daily for behavior, 
reactivity, appearance, and defecation. Grafts developed in situ for 12-16 weeks prior to 
manipulation. 
 
Tissue processing 
Mice were sacrificed and xenograft tissues trisected for histology, fluorescence staining, and 
electron microscopy. Samples for histological analysis were fixed in neutral buffered 4% 
paraformaldehyde (PFA) and paraffin embedded. Alkaline phosphatase staining using Fast red 
(Roche) was used to detect neutral mucins in goblet cells and on the villi. For 
immunofluorescence staining fresh xenograft tissue was fixed in 2.5% PFA, incubated with 15% 
(w/v) sucrose for 12 hours at 4°C and frozen in Tissue-Tek® (EMS, Hatfield, PA) embedding 
medium. For electron microscopy, samples were fixed in 4 % buffered glutaraldehyde followed 
by dehydration in graded ethanol, and the samples were embedded in a Polybed/Araldite 6500 
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mixture (Polysciences, Warrington, Pennsylvania, USA). The ultrathin sections were contrasted 
with uranyl acetate and lead citrate and studied with a Tecnai 12 (Phillips, Eindhoven, The 
Netherlands) TEM equipped with MegaView II CCD camera and AnalySIS version 3.0 software. 
 
Immunohistochemistry 
Paraffin embedded tissues were sectioned at a thickness of 5 µm, deparaffinized with 
xylene and hydrated through a graded series of ethanol. After antigen retrieval with 0.1 M sodium 
citrate, slides were blocked with 10% goat serum for 30 minutes. Endogenous peroxidase activity 
was quenched with 3% hydrogen peroxide in methanol. The sections were incubated with the 
primary antibodies PCNA (sc-25280; Santa Cruz Biotechnology) and anti-α-SMA antibody 
(ab5694; Abcam) and then with a biotinylated horse anti-mouse IgG (Vector Laboratories Inc.) 
and the avidin-biotinylated horseradish peroxidase complex. Staining was developed using 3,3’-
diaminobenzidine (Vector)  
For immunofluorescence staining paraffin sections were incubated for 45 minutes with the 
following primary antibodies: mouse anti-Tuj1 (Covance), human anti-neuronal nuclear antibody-
1 (HuC/D; 1:4,000; generous gift from Dr. Vanda Lennon); rabbit anti-nNOS (1:500, Santa Cruz 
Biotechnology), rabbit anti-human c-kit (DAKO), rabbit anti-PGP9.5 (Cedarlane), rabbit anti-S-
100 (NeoMarkers), pan-cytokeratin (Santa Cruz Biotechnology), huCD45 (Abcam), muCD45 
(Abcam). Secondary antibodies included Alexa Fluor 594 conjugated anti–mouse IgG, Alexa 
Fluor 594 and 488 conjugated anti–rabbit, and Alexa Fluor 594 conjugated anti–human IgG (Life 
Technologies; Carlsbad, CA, USA). Cell nuclei were stained with DAPI (Vector). Images were 
captured with a Nikon 80i microscope. 
 
Results  
Abdominal xenografts.  Intestinal tissue, including either small or large intestine, was harvested 
from human fetuses at 12-18 weeks gestation and transplanted into immunocompromised SCID 
mice. Recipient mice were 6-8 weeks of age. The graft was positioned along the mesenteric side 
of the jejunum of recipient mice (Figure 1A). Prior to transplantation, the intestine was 
confirmed to have normal cytoarchitecture, including a normal-appearing ENS (Figure 1B). A 
total of 18 mice were transplanted with fetal gut segments from 9 different donors. Recipients 
were maintained for 6-8 weeks and graft survival was 100%. At the time of harvest the graft 
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shows obvious growth (Figure 1C) and preserved histology, as shown in Figure 1D, which 
demonstrates the grafted human intestine adjacent to the host mouse intestine. Despite the large 
size of the transplanted graft relative to the host intestine, no evidence of obstruction of the 
mouse intestine was observed. 
 
The ENS of the xenograft contains normal-appearing enteric ganglia (Figure 1E), shown by 
immunofluorescent labeling of both submucosal and myenteric plexuses with the enteric 
neuronal antibody, Tuj1 (Figure 1F). S100+ glial cells are demonstrated both in the ganglia 
(Figure 1G) and in the lamina propria (Figure 1H). The ganglia also contain Hu+ neurons (Figure 
1G), as well as enteric neurons immunoreactive to PGP9.5 (Figure 1I), calretinin (Figure 1J), and 
nNOS (Figure 1K). c-Kit-expressing interstitial cells of Cajal (ICC) are also present (Figure 1L). 
  
Subcutaneous xenografts.  Human fetal intestine was transplanted subcutaneously into SCID 
mice (Figure 2A), where they were maintained for 12-16 weeks. Following harvesting of the 
xenograft, the intestine appeared viable and grossly normal. Epithelial cell proliferation within 
the crypts was confirmed by PCNA staining (Figure 2B). Normal development of the smooth 
muscle layers (Figure 2C) and ENS (Figure 2D) were also confirmed by immunostaining. As 
shown in Figure 2D, enteric ganglia containing Hu+ neurons and S100+ glia are present in the 
submucosal and myenteric plexuses. Villi have a normal structure, with epithelial cells staining 
for cytokeratin (Figure 2E). Interestingly, CD45+ immune cells from both the mouse host and 
the human graft are present within the transplanted tissue (Figure 2F). Alkaline phosphatase 
staining demonstrates the presence of a normal epithelial layer with an intact brush border, 
suggesting the capacity for functional absorption (Figure 2G), and electron microscopy confirms 
normal microvillus architecture (Figure 2H). 
 
Discussion 
 Subcutaneous transplantation of fetal rodent intestine into rodent hosts was described 
over 45 years ago  (11) and has been extensively studied since then with respect to its anatomical 
and functional development (12). Transplantation of fetal human intestine into a nude mouse was 
first described in 1991 (2). Human fetal small and large intestine was able to be maintained for 
up to six months in 62% of the transplants and demonstrated neovascularization with age-
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appropriate maturation and normal gross histology of all intestinal elements. Studies using this 
platform have focused on investigation of human-specific enteropathogens and the inflammatory 
and immunological responses they evoke (3-10, 13). There has been no study of the human ENS 
in this model. However, Tanaka et al (14) performed a careful characterization of the ENS in 
fetal rat gut transplanted into rats. These workers reported hyperganglionosis and 
hyperinnervation in the transplanted rat intestine. In the present study of human grafts, we 
observed normal development and differentiation of enteric neurons and glial cells. Further 
analyses are needed to more precisely determine whether neuronal and glial cell numbers, 
morphology, or subtypes differ from normal human intestine. Moreover, we observed 
spontaneous peristaltic activity when the grafts were harvested, suggesting that the gut remains 
functionally active throughout the transplantation period, although quantitative analyses of 
motility are needed. 
 One goal of this study was to develop a novel platform that would allow long-term 
survival, growth, and maturation of fetal human intestine in a vascularized environment and 
thereby provide a new way to study human fetal ENS maturation and the development of 
regenerative stem cell-based therapies for neurointestinal diseases. In comparing the merits of 
intra-abdominal and subcutaneous grafts, we did not detect any histologic differences in their 
phenotypes. While technically more difficult to perform due to the need for laparotomy, intra-
abdominal grafts may have several advantages over subcutaneous grafts. First, they are readily 
vascularized by the intestinal mesentery on which they develop. Second, their growth may be 
less constrained than in the subcutaneous space. Third, there may be advantages to being in the 
microenvironment of the host intestine rather than in a location where the gut does not normally 
reside.  
Neurointestinal diseases, including esophageal achalasia, gastroparesis, chronic intestinal 
pseudo-obstruction, and Hirschsprung disease, represent major causes of morbidity (15). Despite 
this, current treatments aim only to alleviate the symptoms rather than correct the underlying 
neurointestinal pathology. ENSC transplantation has the potential to replace the abnormal or 
missing enteric neurons and thereby restore gastrointestinal function in these patients, for 
example in those with Hirschsprung disease. However, existing model systems to develop and 
test this novel approach are limited due to the host animal’s clinical deterioration and premature 
mortality as a result of the congenital aganglionosis. Furthermore, for future clinical application, 
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ENSC transplantation studies need to be performed in human intestine, but current organ culture 
techniques allow only short-term tissue survival.  
Transplantation of human fetal gut into SCID mice, especially the novel intra-abdominal 
xenograft model, will allow prolonged studies of the effects of ESNC transplantation in human 
intestine. It can also serve as a platform for syngeneic transplants of mouse gut from transgenic 
lines or experimental manipulations that normally do not survive long enough for these types of 
experiments. Moreover, while our focus is on the use of this model system for ENSC 
transplantation studies, the intra-abdominal gut xenografts are also a valuable platform for the 
study of normal development and mechanisms of disease, especially in those cases where the use 
of human tissue is of particular value. 
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Figure Legends 
 
 
Figure 1. Abdominal human gut xenograft model in SCID mice. 
Human 15-week-old fetal gut (dashed line) was transplanted onto the mesentery adjacent to the 
mouse jejunum (A, graft marked with black arrows). Cross-section of hematoxylin-eosin stained 
fetal large intestine before abdominal transplantation showing the normal cytoarchitecture of the 
grafted intestine (B; inset shows magnified view of myenteric plexus; arrowheads). The 
transplant grows and develops over 2-3 months into grossly normal-appearing intestinal tissue 
(C). Histology of the mature xenograft is seen adjacent to the normal host jejunum (D). A well-
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developed myenteric plexus (arrows) is seen between the smooth muscle layers (E). 
Immunofluorescence of the xenograft ENS shows Tuj1+ neurons and processes in both plexuses 
(F). Hu+ myenteric neurons and S100+ myenteric glia (G), S100+ mucosal glia (H) and multiple 
neuronal subtypes (I-K) are present in the xenograft. Interstitial cells of Cajal are seen with c-kit 
staining (L). 
 
 
 
 
Figure 2. Subcutaneous human gut xenografts. 
Human fetal gut was transplanted subcutaneously into a SCID mouse (A). Histology of the 
mature gut xenograft shows proliferative PCNA+ cells at the base of the epithelial crypts (B), 
actin+ smooth muscle cells (C), and Hu+ enteric neurons with S100+ glial cells within the 
submucosal (smp) and myenteric (mp) plexuses (D). Villous epithelial cells in the xenografts 
stain with anti-cytokeratin antibodies (E; arrowheads shows goblet cells). Species-specific CD45 
antibodies demonstrate the presence of both human and mouse immune cells in the xenografts 
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(F). Xenografts show strong brush border alkaline phosphatase activity with Fast Red staining 
(G) and well-developed microvilli by electron microscopy (H). 
 
